Navigation Links
EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available in U.S. Pharmacies for Patients with Hypertension
Date:2/6/2012

y blocking the action of angiotensin II, a vasopressor hormone, which naturally exists within the body. When EDARBI blocks the angiotensin II receptor, blood vessels can stay relaxed and open, and blood pressure can be reduced. EDARBI is indicated for the treatment of hypertension to lower blood pressure in adults, either alone or in combination with other antihypertensive agents. The recommended dose of EDARBI in adults is 80 mg taken once daily. A starting dose of 40 mg may be appropriate for patients on high doses of diuretics. EDARBI is approved in the United States, Europe and Mexico.

EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is a fixed-dose combination therapy for the treatment of hypertension that combines azilsartan medoxomil and chlorthalidone in a single tablet. Chlorthalidone reduces the amount of water in the body by increasing the flow of urine, which helps lower blood pressure. EDARBYCLOR is indicated for the treatment of hypertension to lower blood pressure; it may be used in patients not adequately controlled with monotherapy and as an initial therapy if a patient is likely to need multiple drugs to achieve blood pressure goals. The recommended starting dose of EDARBYCLOR in adults is 40/12.5 mg taken orally once daily. The maximal dose is 40/25 mg.

Important Safety Information
Boxed Warning for FETAL TOXICITY

When pregnancy is detected, patients should discontinue EDARBI or EDARBYCLOR as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

EDARBYCLOR is contraindicated in patients with anuria.

Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. When pregnancy is detected, patients should discontinue EDARBI or EDARBYCLOR as soon as possible. Thiazides cross the placental
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
2. EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension
3. FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
4. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
5. New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
6. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
7. NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription
8. PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
9. Nearly 9 Million Kaiser Permanente Health Records Securely Available on Mobile Devices
10. Edgemont - New Fluoxetine Tablets, 60 mg Now Available
11. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... WOONSOCKET, R.I. , Oct. 2, 2014  MinuteClinic, the largest ... the United States , has opened its first walk-in clinics ... two CVS/pharmacy stores in Corpus Christi and ... Corpus Christi in December. The ... new clinics nationwide in 2014. With the Corpus Christi ...
(Date:10/2/2014)... , Oct. 2, 2014  Isis Pharmaceuticals, ... following webcast:What: , Webcast and conference call to ... 2 clinical studies of ISIS-SMN Rx in ... which will be presented on the morning (CEST) ... World Muscle Society in Berlin, GermanyWhen:Friday, October 10 ...
(Date:10/2/2014)... Oct. 1, 2014 The global high content ... by the ,Threat of Obsolescence, wherein technologies as well ... Pharmaceutical and biotechnology companies as well as academic and ... screening as a powerful research tool in drug discovery. ... segment in the high content screening market. In high ...
Breaking Medicine Technology:First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 2First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 3Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 3
... TUMWATER, Wash., Dec. 13, 2011  The Washington Health Care ... COMS Interactive , LLC (COMS or Clinical ... is in alignment with WHCA,s stated objective, which is ... provide long-term health care residents with the highest quality ...
... 2011 IsZo Capital Management LP, one of the largest ... TAROF ), announced today that it delivered the following ... it withdraw immediately from the agenda for the upcoming annual ... December 13, 2011 Board of Directors of Taro ...
Cached Medicine Technology:WHCA Selects COMS Interactive as Affinity Partner 2WHCA Selects COMS Interactive as Affinity Partner 3IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 2IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 3IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 4IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 5
(Date:10/2/2014)... 2014 Robins & Morton received ... Builders and Contractors (ABC) of Alabama. , ABC ... held at Sheraton Birmingham Hotel., , ... Million to $25 Million, Obelisk Award (First Place) ... Government $10 Million to $25 Million, Obelisk Award ...
(Date:10/2/2014)... Amy Norton HealthDay Reporter ... girls free birth control -- especially long-acting implanted devices -- ... current U.S. average, new findings suggest. In a study ... contraceptives substantially cut the girls, rates of unplanned pregnancy and ... per 1,000 girls -- versus a rate of 158 per ...
(Date:10/2/2014)... 1, 2014 (HealthDay News) -- Children with autism are ... fully capable of being more active, a small study ... of 29 children, some with autism and some without. ... of moderate physical activity and 70 more minutes each ... children with autism scored lower on strength, but had ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... Hospitals that pull out all the stops to rescue ... lives, but the cost of such heroism is questionable, ... about 5 percent better at saving elderly patients with ... operate with less intensity, said senior author Dr. Amir ...
(Date:10/1/2014)... associated with Alzheimer,s disease; however, researchers are still looking ... agent of the onset and development of the disease. ... is not harmful when found in isolation but only ... form the so-called amyloid fibrils , "We are not ... multiple ones because each aggregate of peptide, which can ...
Breaking Medicine News(10 mins):Health News:Robins & Morton wins nine awards from Associated Builders and Contractors 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 3Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 4Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... Persons treated with Interferon (IFN)to treat chronic hepatitis C ... phase itself//. Retinopathy can develop within two weeks from commencement ... in the journal Investigative Ophthalmology & Visual Science (IOVS)in the ... in Japan gauged the changes in diameter of ...
... more daughters and no sons, may have a greater risk ... team of Israeli researchers compared families of men diagnosed with ... daughters and risk of prostate cancer were related. ... may be a link but the factors responsible for prostate ...
... a little gadget that can be used for 15 minutes ... device, developed by New York based company Helicor, is under ... users to lower their own heartbeat by regulated deep breathing, ... device, also on trial for several other conditions including anxiety ...
... in maintaining weight and a healthy lifestyle. On the same ... and diuretics are superfluous with no proven benefits. , ... alcohol as a temporary measure to freshen up the kidneys ... to pump the body with more antioxidants. Drinking lots of ...
... a premature baby is up for women who have ... eliminate precancerous cells, called LEEP or loop// incision, researchers ... a study involving 5000 women, researchers said that nearly ... incision was avoided. Babies born prematurely are seen battling ...
... girls might want to have another look at that ... to recent studies, teenage girls who read articles on ... prone to resort to drastic weight reducing techniques such ... who don’t. ,The study, published in Pediatrics' January ...
Cached Medicine News:Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2Health News:Drop That Glossy, Girl! 2
Straight shafts with 1 x 2 teeth. Serrated handle, non-magnetic and polished finish....
Straight shafts with pointed 4.5 mm tying surfaces. Scalloped wide handle with dull finish....
Straight shafts with 0.5 mm teeth and 6 mm tying platform. Wide serrated handle with thumb catch lock and polished finish....
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Medicine Products: